ERA-NET subsidy for translational research on human ovarian tumour

Peter Horvatovich, Analytical Biochemistry (Groningen Research institute of Pharmacy), received as consortium partner in TRANSCAN-2, ERA-NET research program 300.000 euro subsidy for translational research on human ovarian tumour heterogeneity to overcome recurrence and resistance to therapy. The project in collaboration with European partners and the labs of Kathrin Thedieck (UMCG), Marco Grzegorczyk (JBI) and Victor Guryev (UMCG) will allow to understand molecular heterogeneity of human primary and metastatic ovarian cancer and open new doors for better patient characterization and personalized treatment of this malignant cancer type, where patients have currently less than 45% of 5-years survival rate.